Account
Articles

High Pharma margins increasing the squeeze on health systems

22/02/2019

Read the article here which focusses on the cost of cancer treatment versus their manufacturing costs.

Author:

Graham Foxon, PhD, MBA
About the Author

Article Tags

Oncology Pricing

Share this article

Related articles

Artificial Intelligence
26.02.2025
World EPA 2025: Evaluating the capabilities of AI ...

AUTHORS: Ella Odams, Richard Sloggett, Graham Foxon OBJECTIVES  To evaluate if ChatGPT is a rel...

Read more
Insider Insights
17.10.2024
A closer look at Spain’s new pharmaceutical acce...

Spain is set to implement a comprehensive reform to its law of guarantees and rational use of medici...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch